Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:09:40 EDT Sat 27 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:INO from 2023-04-27 to 2024-04-26 - 30 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2024-04-15 18:39
U
U:INO
News Release
200
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
2024-03-26 18:28
U
U:INO
News Release
200
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
2024-03-06 16:05
U
U:INO
News Release
200
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
2024-03-06 07:00
U
U:INO
News Release
200
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
2024-02-21 08:00
U
U:INO
News Release
200
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
2024-02-07 11:46
U
U:INO
News Release
200
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-02-02 08:00
U
U:INO
News Release
200
INOVIO Reports Inducement Grant Under Inducement Plan
2024-01-23 08:00
U
U:INO
News Release
200
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
2024-01-22 08:00
U
U:INO
News Release
200
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
2024-01-04 08:00
U
U:INO
News Release
200
INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI ¢ „ ¢ (toripalimab-tpzi)
2024-01-03 08:00
U
U:INO
News Release
200
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
2023-11-09 16:05
U
U:INO
News Release
200
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
2023-11-01 08:00
U
U:INO
News Release
200
INOVIO Reports Inducement Grants Under Inducement Plan
2023-10-26 08:00
U
U:INO
News Release
200
INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023
2023-10-10 08:00
U
U:INO
News Release
200
INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program
2023-09-27 19:39
U
U:INO
News Release
200
Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million
2023-09-07 08:00
U
U:INO
News Release
200
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis
2023-08-29 08:00
U
U:INO
News Release
200
INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-09 16:05
U
U:INO
News Release
200
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
2023-08-04 08:00
U
U:INO
News Release
200
INOVIO Reports Inducement Grants Under Inducement Plan
2023-07-26 09:32
U
U:INO
News Release
200
INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023
2023-06-23 16:10
U
U:INO
News Release
200
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
2023-06-01 08:00
U
U:INO
News Release
200
INOVIO Reports Inducement Grants Under Inducement Plan
2023-05-25 08:00
U
U:INO
News Release
200
INOVIO to Present at the 2023 Jefferies Healthcare Conference
2023-05-23 16:13
U
U:INO
News Release
200
INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
2023-05-10 16:05
U
U:INO
News Release
200
INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights
2023-05-08 08:00
U
U:INO
News Release
200
New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023
2023-05-05 08:00
U
U:INO
News Release
200
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference
2023-04-28 08:00
U
U:INO
News Release
200
INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023
2023-04-27 08:00
U
U:INO
News Release
200
INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis at COSM 2023